Skip to main content
Erschienen in: Diabetologia 4/2005

01.04.2005 | Article

Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study

verfasst von: T. Tillin, N. Forouhi, D. G. Johnston, P. M. McKeigue, N. Chaturvedi, I. F. Godsland

Erschienen in: Diabetologia | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to study differences in the prevalence of the metabolic syndrome and its associations with prevalent CHD according to ethnicity and sex.

Methods

We performed a combined analysis of two population-based cross-sectional studies conducted between 1988 and 1991 that followed identical protocols. Participants (aged 40–69 years) comprised 2,346 Europeans (76% male), 1,711 South Asians (83% male) and 803 African-Caribbeans (57% male) resident in west London. Fasting blood, overnight urine collection, clinical and anthropometric measurements were performed. Clinical history or major ECG changes defined prevalent CHD. The metabolic syndrome was defined according to the criteria recommended by the World Health Organization (WHO) and the National Cholesterol Education Programme (NCEP).

Results

The prevalence of the metabolic syndrome was highest in South Asians (WHO, men 46%, women 31%; NCEP, men 29%, women 32%) and lowest in European women (WHO, 9%; NCEP, 14%). The prevalence of CHD was 10% in South Asian men, 9% in European men, 5–6% in African-Caribbeans and European women, and 2% in South Asian women. The metabolic syndrome was associated with prevalent CHD in European men [NCEP, odds ratio (OR)=1.6, 95% CI 1.2–2.4; WHO, OR=1.7, 95% CI 1.2–2.5] and South Asian men (NCEP, OR=2.1, 95% CI 1.5–3.1; WHO, OR=1.6, 95% CI 1.1–2.3). Associations with CHD were weaker in African-Caribbeans and were inconsistent among European women.

Conclusions/interpretation

The current definitions of the metabolic syndrome give an inconsistent picture of cardiovascular disease risk when applied to different ethnic groups within the UK. Prospective studies are needed to validate workable ethnic-specific definitions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Office for National Statistics (2002) Mortality statistics. Review of the Registrar General on deaths by cause, sex and age in England and Wales. The Stationery Office, London Office for National Statistics (2002) Mortality statistics. Review of the Registrar General on deaths by cause, sex and age in England and Wales. The Stationery Office, London
2.
Zurück zum Zitat Wild S, McKeigue PM (1997) Cross-sectional analysis of mortality by country of birth in England and Wales 1970–1992. BMJ 314:705–710 Wild S, McKeigue PM (1997) Cross-sectional analysis of mortality by country of birth in England and Wales 1970–1992. BMJ 314:705–710
3.
Zurück zum Zitat Reaven GM (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMed Reaven GM (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMed
4.
Zurück zum Zitat McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386CrossRef McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386CrossRef
5.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497
6.
Zurück zum Zitat World Health Organization, Department of Non-Communicable Disease Surveillance (1999) Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva World Health Organization, Department of Non-Communicable Disease Surveillance (1999) Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
7.
Zurück zum Zitat Bonora E, Kiechl S, Willeit J et al (2003) Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26:1251–1257 Bonora E, Kiechl S, Willeit J et al (2003) Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26:1251–1257
8.
Zurück zum Zitat Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed
9.
Zurück zum Zitat Sattar N, Gaw A, Scherbakova O et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414–419CrossRef Sattar N, Gaw A, Scherbakova O et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414–419CrossRef
10.
Zurück zum Zitat Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107:391–397CrossRef Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107:391–397CrossRef
11.
Zurück zum Zitat Isomaa B, Almgren P, Tuomi T (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–691 Isomaa B, Almgren P, Tuomi T (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–691
12.
Zurück zum Zitat Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 164:1066–1076CrossRefPubMed Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 164:1066–1076CrossRefPubMed
13.
Zurück zum Zitat Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart Study (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257CrossRef Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart Study (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251–1257CrossRef
14.
Zurück zum Zitat Chaturvedi N, McKeigue PM, Marmot MG (1993) Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension 22:90–96 Chaturvedi N, McKeigue PM, Marmot MG (1993) Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension 22:90–96
15.
Zurück zum Zitat Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443CrossRefPubMed Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443CrossRefPubMed
16.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 7:412–419CrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 7:412–419CrossRef
17.
Zurück zum Zitat Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470 Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
18.
Zurück zum Zitat Godsland IF, Jeffs JAR, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157–1166PubMed Godsland IF, Jeffs JAR, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157–1166PubMed
19.
Zurück zum Zitat Mattix HJ, Hsu CY, Shaykevich S, Curhan G (2002) Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13:1034–1039 Mattix HJ, Hsu CY, Shaykevich S, Curhan G (2002) Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13:1034–1039
20.
Zurück zum Zitat Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26: 575–581 Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26: 575–581
21.
Zurück zum Zitat Anand SS, Yi Q, Gerstein H et al (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108:420–425CrossRef Anand SS, Yi Q, Gerstein H et al (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108:420–425CrossRef
22.
Zurück zum Zitat Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077CrossRefPubMed Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070–1077CrossRefPubMed
23.
Zurück zum Zitat Chaturvedi N, McKeigue PM, Marmot MG (1994) Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 37:765–772 Chaturvedi N, McKeigue PM, Marmot MG (1994) Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 37:765–772
24.
Zurück zum Zitat The European Group for the Study of Insulin Resistance (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376 The European Group for the Study of Insulin Resistance (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376
Metadaten
Titel
Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study
verfasst von
T. Tillin
N. Forouhi
D. G. Johnston
P. M. McKeigue
N. Chaturvedi
I. F. Godsland
Publikationsdatum
01.04.2005
Erschienen in
Diabetologia / Ausgabe 4/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1689-3

Weitere Artikel der Ausgabe 4/2005

Diabetologia 4/2005 Zur Ausgabe

Letters

Comment

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.